MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. The company was founded in 1991 and is based in Valencia, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/01/2017 17:49 PDT] Market Maker Surveillance Report. MNKD, Losing Stocks With Lowest Price Friction For Friday, September 1st 2017
• [08/30/2017 17:49 PDT] Market Maker Surveillance Report. MNKD, Winning Stocks With Lowest Price Friction For Wednesday, August 30th 2017